Literature DB >> 30636495

A Nationwide Comparison Between Sepsis-2 and Sepsis-3 Definition in Japan.

Shuhei Takauji1, Mineji Hayakawa2, Satoshi Fujita1.   

Abstract

BACKGROUND: Currently, it remains controversial whether the Sepsis-3 definition provides the most appropriate criteria for clinical use. The purpose of this study was to compare between the Sepsis-2 and Sepsis-3 definitions using Japan's nationwide registry.
METHODS: Data were obtained from a multicenter registry conducted at 42 intensive care units (ICUs) throughout Japan, in which patients received treatment for severe sepsis or septic shock between January 2011 and December 2013.
RESULTS: A total of 2797 patients diagnosed using the Sepsis-2 criteria were included in the present study. These patients were categorized into "Severe sepsis" (n = 1154) and "Sepsis-2 shock" (n = 1643) groups. Among the "Sepsis-2 shock" group, patients who did not meet the Sepsis-3 criteria for septic shock were categorized into the "Sepsis-2 shock-only" (n = 448, 27.3%) group, while patients who met the Sepsis-3 criteria for septic shock were categorized into "Sepsis-3 shock (n = 1195, 72.7%)" group. The ICU mortality in the "Sepsis-3 shock" group, "Sepsis-2 shock-only" group, and "Severe sepsis" group was 28.5%, 10.9%, and 14.1%, respectively. We observed no significant difference between the "Severe sepsis" and "Sepsis-2 shock-only" groups in terms of in-hospital survival (P = .098), while the "Sepsis-3 shock" group had the highest in-hospital mortality rate (P < .001). In a multivariate logistic regression analysis, liver insufficiency and immunocompromised status were independent prognostic factors in the "Sepsis-2 shock-only" group. In contrast, chronic heart disease and chronic hemodialysis were independent prognostic factors in the "Sepsis-3 shock" group.
CONCLUSIONS: The ICU mortality of the "Sepsis-2 shock-only" group was significantly low. Besides septic shock diagnosed by the Sepsis-3 definition selects patients with more severe cases of sepsis among the "Sepsis-2 shock" group.

Entities:  

Keywords:  Sepsis-3; mortality; organ failure; septic shock

Mesh:

Year:  2019        PMID: 30636495     DOI: 10.1177/0885066618823151

Source DB:  PubMed          Journal:  J Intensive Care Med        ISSN: 0885-0666            Impact factor:   3.510


  6 in total

1.  Trends in bacterial sepsis incidence and mortality in France between 2015 and 2019 based on National Health Data System (Système National des données de Santé (SNDS)): a retrospective observational study.

Authors:  Laurence Watier; Christian Brun-Buisson; Fanny Pandolfi; Didier Guillemot
Journal:  BMJ Open       Date:  2022-05-24       Impact factor: 3.006

2.  A Comparison of Sepsis-2 (Systemic Inflammatory Response Syndrome Based) to Sepsis-3 (Sequential Organ Failure Assessment Based) Definitions-A Multicenter Retrospective Study.

Authors:  Milo Engoren; Troy Seelhammer; Robert E Freundlich; Michael D Maile; Matthew J G Sigakis; Thomas A Schwann
Journal:  Crit Care Med       Date:  2020-09       Impact factor: 9.296

3.  A Data-Driven Approach to Predicting Septic Shock in the Intensive Care Unit.

Authors:  Christopher R Yee; Niven R Narain; Viatcheslav R Akmaev; Vijetha Vemulapalli
Journal:  Biomed Inform Insights       Date:  2019-11-04

4.  A Novel Nomogram for Predicting Post-Operative Sepsis for Patients With Solitary, Unilateral and Proximal Ureteral Stones After Treatment Using Percutaneous Nephrolithotomy or Flexible Ureteroscopy.

Authors:  Jian-Xuan Sun; Jin-Zhou Xu; Chen-Qian Liu; Yang Xun; Jun-Lin Lu; Meng-Yao Xu; Ye An; Jia Hu; Cong Li; Qi-Dong Xia; Shao-Gang Wang
Journal:  Front Surg       Date:  2022-04-15

Review 5.  The Surviving Sepsis Campaign: research priorities for the administration, epidemiology, scoring and identification of sepsis.

Authors:  Mark E Nunnally; Ricard Ferrer; Greg S Martin; Ignacio Martin-Loeches; Flavia R Machado; Daniel De Backer; Craig M Coopersmith; Clifford S Deutschman
Journal:  Intensive Care Med Exp       Date:  2021-07-02

6.  Circulating Microvesicle-Associated Inducible Nitric Oxide Synthase Is a Novel Therapeutic Target to Treat Sepsis: Current Status and Future Considerations.

Authors:  Robert J Webber; Richard M Sweet; Douglas S Webber
Journal:  Int J Mol Sci       Date:  2021-12-13       Impact factor: 5.923

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.